These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 18447405)

  • 1. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.
    Gupta P; O'Mahony MS
    Drugs Aging; 2008; 25(5):415-43. PubMed ID: 18447405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.
    Newnham DM
    Drug Saf; 2001; 24(14):1065-80. PubMed ID: 11735662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic responses in asthma and COPD. Bronchodilators.
    Donohue JF
    Chest; 2004 Aug; 126(2 Suppl):125S-137S; discussion 159S-161S. PubMed ID: 15302773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.
    McCrory DC; Brown CD
    Cochrane Database Syst Rev; 2002; 2003(4):CD003900. PubMed ID: 12519615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming gaps in the management of asthma in older patients: new insights.
    Barua P; O'Mahony MS
    Drugs Aging; 2005; 22(12):1029-59. PubMed ID: 16363886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF
    Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.
    Rossi A; Khirani S; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):521-9. PubMed ID: 19281071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease.
    Sethi S; Cote C
    Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
    Salpeter SR; Buckley NS
    Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.
    Salpeter SR
    Int J Chron Obstruct Pulmon Dis; 2007; 2(1):11-8. PubMed ID: 18044061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.
    Saberi F; O'Donnell DE
    Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA; Donohue JF
    Proc Am Thorac Soc; 2007 Oct; 4(7):526-34. PubMed ID: 17878465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.